Qiming Corporate GP VI, Ltd. bought ALMR
April 20, 2026 · Form 4 insider transaction
Qiming Corporate GP VI, Ltd. bought 1,605,645 shares of Alamar Biosciences, Inc., a transaction worth N/A. The trade was recorded as conversion of a derivative and disclosed on an SEC Form 4, filed 2 days after the transaction.
Footnotes
Each share of the Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock converted into 0.4136 share of Class B Common Stock at the closing of the initial public offering. The Series A-3 Preferred Stock, Series A-4 Preferred Stock and Series C Preferred Stock had no expiration date.; These shares are held of record by Qiming Venture Partners VIII Investments, LLC ("QVP VIII LLC"). Qiming GP VIII, LLC, through two parallel intermediaries, serves as the indirect general partner of QVP VIII LLC and may be deemed to have voting and dispositive power over the shares held by QVP VIII LLC. Qiming GP VIII, LLC disclaims beneficial ownership of such shares, except to the extent of its proportionate pecuniary interest therein.